Molbio Diagnostics has been awarded the prestigious Kochon Prize 2024 by the Stop TB Partnership for its portable Truenat PCR platform, recognised for revolutionising TB diagnostics in low-resource settings. The WHO- and ICMR-endorsed system enables rapid, on-site detection without reliance on extensive lab infrastructure. Molbio has deployed over 10,000 devices across 80+ countries. CEO Sriram Natarajan announced the company would contribute the $65,000 prize money back to the Stop TB Partnership, reinforcing its commitment to equitable TB care worldwide.